Straits Research Highlights Robust Growth in the Global Biologics Market, Projected to Reach USD 506 Billion by 2030
Straits Research, a leading market research and consulting firm, has unveiled its latest insights into the burgeoning global biologics market. The market, valued at USD 343 billion in 2021, is projected to grow at a compound annual growth rate (CAGR) of 4%, reaching an impressive USD 506 billion by 2030.
Market Definition
Biologics, also known as biopharmaceuticals, are products derived from living organisms used in the prevention, treatment, or cure of diseases. Their applications span across multiple therapeutic areas, making them a cornerstone of modern medicine.
Get a Full PDF Sample Copy of the Report @ https://straitsresearch.com/report/biologics-market/request-sample
Market Dynamics
The biologics market is characterized by dynamic shifts, driven by key trends, drivers, and opportunities:
Latest Key Trends
- Advancements in Biomanufacturing Technologies: The adoption of next-generation biomanufacturing processes, such as single-use systems and continuous bioprocessing, is enhancing production efficiency and reducing costs.
- Personalized Medicine and Precision Therapeutics: Increasing focus on tailored treatments has led to innovations in biologics targeting specific patient profiles.
Market Drivers
- Rising Prevalence of Chronic Diseases: Growing incidences of cancer, diabetes, and autoimmune diseases are fueling the demand for biologics.
- Government Support and Funding: Increasing investments in biopharmaceutical RD by governments and private entities are accelerating product development.
Market Opportunities
- Expansion into Emerging Markets: Rapid urbanization, improving healthcare infrastructure, and growing awareness in regions like Asia-Pacific present significant growth potential.
- Breakthroughs in Gene and Cell Therapies: Innovations in genetic engineering and cell-based therapies offer new avenues for biologics development.
Market Segmentation
The biologics market is segmented as follows:
By Source:
- Mammalian
- Microbial
By Manufacturing:
- In-house
- Outsourced
By Product:
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Antisense RNAi Therapeutics
- Others
By Disease Category:
- Oncology
- Infectious Diseases
- Immunological Disorders
- Cardiovascular Disorders
- Hematological Disorders
- Others
By Type:
- Tumor Necrosis Factor (TNF) Inhibitor
- T-cell Inhibitor
- Selective Co-stimulation Modulators
- Interleukin-6 (IL-6) or Interleukin-17 Blocker
- Interleukin-1 (IL-1) Blocker
- B-cell Inhibitor
By Drug Class:
- Monoclonal Antibody
- Recombinant Insulin
- Vaccine
- Blood Factor
- Human Growth Hormone
- Erythropoietin
- Fusion Protein
- Recombinant Enzyme
- Interferon
- Colony-stimulating Factor
- Gene Therapy
- Cell Therapy
- Oligonucleotides
- Peptide
- Botulinum Toxin
- Others
By Source:
- Microbial
- Mammalian
- Others
By Drug Type:
- Branded Drugs
- Generic Drugs
By Mode of Purchase:
- Prescription Drugs
- Over-the-counter (OTC) Drugs
By Dosage Form:
- Injection
- Tablets
- Others
By Route of Administration:
- Parenteral
- Oral
- Others
By End-Users:
- Hospitals
- Specialty Clinics
- Homecare
- Others
By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Access Detailed Segmentation @ https://straitsresearch.com/report/biologics-market/segmentation
Key Players in the Biologics Market
The competitive landscape of the biologics market features prominent players such as:
- Bristol-Myers Squibb Company
- Merck KGaA
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Johnson Johnson Services Inc.
- Hoffmann La Roche Ltd
Regional Insights
- Dominated Region: North America leads the global biologics market, driven by advanced healthcare infrastructure and robust RD activities.
- Fastest Growing Region: Europe is anticipated to witness the fastest growth, fueled by increased adoption of innovative therapies and supportive regulatory frameworks.
For More Information or Query or Customization Before Buying, Visit @ https://straitsresearch.com/buy-now/biologics-market
About Straits Research
Straits Research is a leading global market research and consulting firm, delivering actionable insights and strategic recommendations across diverse industries. With a focus on accuracy and innovation, we empower businesses to navigate complex markets and achieve sustainable growth.
Contact Us
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846
